ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析

◆英語タイトル:ImmunoGen Inc (IMGN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013835
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer including ovarian cancer, solid tumors, endometrial cancer, multiple myeloma, glioblastoma, breast, and bladder cancer. ImmunoGen also licenses its ADC technology to its partner pharmaceutical companies to develop anticancer compounds. The company focuses its research on evaluation of new targets, new antibodies, linkers and cytotoxic agents, advancement of internal product candidates through clinical trials, and others. ImmunoGen is headquartered in Waltham, Massachusetts, the US.

ImmunoGen Inc (IMGN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ImmunoGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ImmunoGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ImmunoGen Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
ImmunoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
ImmunoGen Inc, Medical Equipment, Deal Details 10
Partnerships 10
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 10
Equity Offering 11
ImmunoGen Raises USD108.4 Million in Public Offering of Shares 11
ImmunoGen Plans to Raise up to USD50 Million in Public Offering 13
ImmunoGen Inc – Key Competitors 14
ImmunoGen Inc – Key Employees 15
ImmunoGen Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Nov 03, 2017: ImmunoGen Reports Recent Progress and Third Quarter 2017 Operating Results 17
Jul 28, 2017: ImmunoGen Reports Recent Progress and Second Quarter 2017 Operating Results 19
May 05, 2017: ImmunoGen Reports Recent Progress and First Quarter 2017 Operating Results 21
Feb 17, 2017: ImmunoGen Reports Recent Progress and Operating Results for Six-Month Period and Quarter Ended December 31, 2016 23
Oct 28, 2016: ImmunoGen Reports Financial Results for Quarter Ended September 30 and Reviews Business Highlights 25
Aug 04, 2016: ImmunoGen Reports Fourth Quarter and Fiscal Year 2016 Financial Results and Provides Quarterly Business Update 27
Apr 29, 2016: ImmunoGen Reports Third Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update 29
Jan 29, 2016: ImmunoGen Reports Second Quarter Fiscal Year 2016 Financial Results and Provides Corporate Update 30
Corporate Communications 32
Jan 23, 2017: ImmunoGen Announces Departure of Sandra Poole 32
Aug 09, 2016: ImmunoGen Announces Departure of Chief Development Officer 33
Apr 26, 2016: ImmunoGen Appoints Mark J. Enyedy as President and Chief Executive Officer 34
Apr 05, 2016: Daniel Junius to Retire as President and CEO of ImmunoGen 35
Other Significant Developments 36
Sep 29, 2016: ImmunoGen Completes Strategic Review to Strengthen the Organization and Drive Long-Term Growth 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
ImmunoGen Inc, Medical Equipment, Key Facts, 2016 2
ImmunoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
ImmunoGen Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
ImmunoGen Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
ImmunoGen Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
ImmunoGen Inc, Deals By Market, 2011 to YTD 2017 8
ImmunoGen Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Ventana Medical Systems Enters into Co-Development Agreement with ImmunoGen 10
ImmunoGen Raises USD108.4 Million in Public Offering of Shares 11
ImmunoGen Plans to Raise up to USD50 Million in Public Offering 13
ImmunoGen Inc, Key Competitors 14
ImmunoGen Inc, Key Employees 15
ImmunoGen Inc, Subsidiaries 16

★海外企業調査レポート[ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AMP Solar Group Inc:電力:M&Aディール及び事業提携情報
    Summary AMP Solar Group Inc (AMP Solar Group) is an alternative energy company that offers solar and photovoltaic turnkey solutions. The company provides development of rooftop and ground based solar projects. It builds solar power projects in government and commercial sectors. AMP Solar Group opera …
  • PT Kalbe Farma Tbk (KLBF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kalbe Farma Tbk (Kalbe) provides a wide range of healthcare solutions. The company undertakes the development, manufacturing and distribution of prescription pharmaceutical products, consumer health products, nutritional products and healthcare services. Its product portfolio comprises br …
  • Nordea Bank AB:企業の戦略・SWOT・財務情報
    Nordea Bank AB - Strategy, SWOT and Corporate Finance Report Summary Nordea Bank AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • SNC-Lavalin Group Inc.:企業の戦略・SWOT・財務分析
    SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report Summary SNC-Lavalin Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Genzyme Corp-医療機器分野:企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • Kawasaki Kisen Kaisha, Ltd.:企業の戦略・SWOT・財務情報
    Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Globavir Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Taikisha Ltd:企業の戦略・SWOT・財務分析
    Taikisha Ltd - Strategy, SWOT and Corporate Finance Report Summary Taikisha Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Entertainment One Ltd.:企業の戦略・SWOT・財務分析
    Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report Summary Entertainment One Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • FDM Group (Holdings) plc (FDM):企業の財務・戦略的SWOT分析
    FDM Group (Holdings) plc (FDM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Bank of Jordan (BOJX):企業の財務・戦略的SWOT分析
    Summary Bank of Jordan is a banking service provider. The company offers corporate services, leasing services, retail services, SMEs services and securities services. It also provides car loans, mortgage, personal loans and credit cards. Bank of Jordan’s retail services include accounts and deposits …
  • Alere Toxicology Plc:企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Keepmoat Ltd:企業の戦略的SWOT分析
    Keepmoat Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Lepu Medical Technology (Beijing) Co Ltd (300003)-医療機器分野:企業M&A・提携分析
    Summary Lepu Medical Technology (Beijing) Co Ltd (Lepu Medical) is a medical device company that designs, develops, and distributes medical equipments. The company’s products include interventional cardiology products, cardiac in vitro diagnosis products, occlusion devices, pacemaker, angiographic e …
  • Sfinks Polska S.A.:企業の戦略・SWOT・財務分析
    Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report Summary Sfinks Polska S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Kirby Corporation:戦略・SWOT・企業財務分析
    Kirby Corporation - Strategy, SWOT and Corporate Finance Report Summary Kirby Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Zumtobel Group AG (ZAG):企業の財務・戦略的SWOT分析
    Zumtobel Group AG (ZAG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Independent Electricity System Operator:企業の戦略的SWOT分析
    Independent Electricity System Operator - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and m …
  • Mondi plc (MNDI):企業の財務・戦略的SWOT分析
    Mondi plc (MNDI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Aura Light International AB:企業の戦略的SWOT分析
    Aura Light International AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆